Production (Stage)
Kewaunee Scientific Corporation
KEQU
$58.45
-$0.69-1.17%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 240.47M | 220.03M | 199.64M | 202.31M | 203.76M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 240.47M | 220.03M | 199.64M | 202.31M | 203.76M |
| Cost of Revenue | 171.62M | 160.57M | 146.53M | 149.68M | 151.70M |
| Gross Profit | 68.86M | 59.46M | 53.11M | 52.63M | 52.05M |
| SG&A Expenses | 51.10M | 44.68M | 36.81M | 35.69M | 33.93M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 222.71M | 205.25M | 183.34M | 185.38M | 185.63M |
| Operating Income | 17.76M | 14.78M | 16.30M | 16.93M | 18.12M |
| Income Before Tax | 14.79M | 8.98M | 11.22M | 12.14M | 13.12M |
| Income Tax Expenses | 3.20M | -8.83M | -7.74M | -6.64M | -5.94M |
| Earnings from Continuing Operations | 11.58 | 17.82 | 18.97 | 18.78 | 19.06 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -178.00K | -234.00K | -217.00K | -308.00K | -304.00K |
| Net Income | 11.41M | 17.58M | 18.75M | 18.47M | 18.75M |
| EBIT | 17.76M | 14.78M | 16.30M | 16.93M | 18.12M |
| EBITDA | 22.24M | 18.79M | 19.55M | 20.15M | 21.25M |
| EPS Basic | 3.99 | 6.15 | 6.55 | 6.44 | 6.54 |
| Normalized Basic EPS | 3.17 | 2.76 | 3.25 | 3.40 | 3.62 |
| EPS Diluted | 3.83 | 5.91 | 6.31 | 6.23 | 6.35 |
| Normalized Diluted EPS | 3.04 | 2.65 | 3.13 | 3.31 | 3.54 |
| Average Basic Shares Outstanding | 11.45M | 11.45M | 11.47M | 11.50M | 11.51M |
| Average Diluted Shares Outstanding | 11.92M | 11.91M | 11.88M | 11.84M | 11.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |